Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCOSOL Paclitaxel in metastatic breast cancer
NCT00096668Phase 2Completed
- Sponsor
- Achieve Life Sciences
- Start
- Oct 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in breast cancer, sponsored by Achieve Life Sciences. Primary endpoint: Tolerability. Started Oct 2004; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00096668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096668.